Bluejay Diagnostics completes Symphony cartridge manufacturing site, bolstering supply-chain resilience
BJDX•Bluejay Diagnostics completed a Symphony cartridge manufacturing site, meeting a Toray license milestone ahead of the Oct. 23, 2026 deadline. The added capacity is intended to support manufacturing pathways in Japan and the U.S.
1. Manufacturing capacity
Bluejay Diagnostics completed establishment of a Symphony cartridge manufacturing site, meeting a Toray license milestone ahead of the Oct. 23, 2026 deadline. The added capacity is intended to reduce supply-chain concentration risk through redundant manufacturing pathways across Japan and the U.S., as the company prepares for regulatory submission and potential commercialization of its Symphony IL-6 test.
